Open AccessThe prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study
Author(s) -
Yang Hang,
Cai YuChen,
Cao Ye,
Song Ming,
An Xin,
Xia Yi,
Wei Jing,
Jiang WenQi,
Shi YanXia
Publication year - 2015
Publication title -
cancer communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 53
ISSN - 2523-3548
DOI - 10.1186/s40880-015-0053-3
Subject(s) - medicine , head and neck squamous cell carcinoma , oncology , biomarker , cancer , head and neck cancer , metastasis , proportional hazards model , lymphoma , immunohistochemistry , pathology , biology , biochemistry
Abstract Introduction Head and neck squamous cell carcinoma (HNSCC) is a common cancer worldwide and has a poor prognosis. A biomarker predicting the clinical outcome of HNSCC patients could be useful in guiding treatment planning. Overexpression of the T lymphoma invasion and metastasis 1 (Tiam1) protein has been implicated in the migration and invasion of neoplasms. However, its role in HNSCC progression needs to be further validated. We detected the expression of Tiam1 in normal and tumor tissues and determined its association with clinical outcomes in patients with HNSCC. Methods We measured the expression of Tiam1 in normal and cancerous tissue samples from the patients with HNSCC treated at Sun Yat‐sen University Cancer Center between 2001 and 2008. The Tiam1 expression was scored from 0 to 12 based on the percentage of positively stained cells and the staining intensity. We then determined the diagnostic performance of this score in predicting overall survival (OS) and disease‐free survival (DFS). Results Of the 194 evaluable patients, those with advanced disease, lymph node metastasis at diagnosis, and recurrence or metastasis during follow‐up had a higher tendency of having high Tiam1 expression as compared with their counterparts ( P < 0.05). The proportion of samples with high Tiam1 expression was also higher in cancerous tissues than in non‐cancerous tissues (57.7% vs. 13.9%, P < 0.001). Cox proportional hazards regression analysis revealed that Tiam1 expression scores of 5 and greater independently predicted short OS and DFS. Conclusion The Tiam1 expression is shown as a promising biomarker of clinical outcomes in patients with HNSCC and should be evaluated in prospective trials.